Generation of transgenic mouse line expressing Kusabira Orange throughout body, including erythrocytes, by random segregation of provirus method

Biochemical and Biophysical Research Communications

Volumn 435, Issue 4, 2013, Pages 586-591

  Hamanaka, Sanae ^a,b   Ooehara, Jun ^a   Morita, Yohei ^a,e   Ema, Hideo ^a,f   Takahashi, Satoru ^b   Miyawaki, Atsushi ^c   Otsu, Makoto ^a   Yamaguchi, Tomoyuki ^a   Onodera, Masafumi ^b,d   Nakauchi, Hiromitsu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^d NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^e UNIVERSITY OF ULM   (Germany)

^f KEIO UNIVERSITY   (Japan)

Author keywords

Hematopoietic stem cell; Kusabira Orange; Retroviral vector; Segregation

Indexed keywords

FLUORESCENT DYE; KUSABIRA ORANGE; PEPTIDES AND PROTEINS; RED FLUORESCENT PROTEIN; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW TRANSPLANTATION; EMBRYO; EMBRYONIC STEM CELL; ERYTHROCYTE; GENETIC PROCEDURES; HEMATOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PROVIRUS; RANDOM SEGREGATION OF PROVIRUS; THROMBOCYTE; TRANSGENIC MOUSE; VIRAL GENE DELIVERY SYSTEM; VIRUS DNA CELL DNA INTERACTION;

ANIMALS; ERYTHROCYTES; GENETIC ENGINEERING; LUMINESCENT PROTEINS; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORGAN SPECIFICITY; PROVIRUSES; TISSUE DISTRIBUTION; TRANSFECTION;

MUS MUSCULUS;

EID: 84878959408     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.017     Document Type: Article

References (18)

1. Karasawa S., Araki T., Nagai T., Mizuno H., Miyawaki A. Cyan-emitting and orange-emitting fluorescent proteins as a donor/acceptor pair for fluorescence resonance energy transfer. Biochem. J. 2004, 381:307-312.
2. Miyawaki A. Fluorescent proteins in a new light. Nat. Biotechnol. 2004, 22:1374-1376.
3. Matz M.V., Fradkov A.F., Labas Y.A., Savitsky A.P., Zaraisky A.G., Markelov M.L., Lukyanov S.A. Fluorescent proteins from nonbioluminescent Anthozoa species. Nat. Biotechnol. 1999, 17:969-973.
4. Campbell R.E., Tour O., Palmer A.E., Steinbach P.A., Baird G.S., Zacharias D.A., Tsien R.Y. A monomeric red fluorescent protein. Proc. Natl. Acad. Sci. USA 2002, 99:7877-7882.
5. Vintersten K., Monetti C., Gertsenstein M., Zhang P., Laszlo L., Biechele S., Nagy A. Mouse in red: red fluorescent protein expression in mouse ES cells, embryos, and adult animals. Genesis 2004, 40:241-246.
6. Stripecke R., Carmen Villacres M., Skelton D., Satake N., Halene S., Kohn D. Immune response to green fluorescent protein: implications for gene therapy. Gene Ther. 1999, 6:1305-1312.
7. Gambotto A., Dworacki G., Cicinnati V., Kenniston T., Steitz J., Tuting T., Robbins P.D., DeLeo A.B. Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope. Gene Ther. 2000, 7:2036-2040.
8. Sanuki S., Hamanaka S., Kaneko S., Otsu M., Karasawa S., Miyawaki A., Nakauchi H., Nagasawa T., Onodera M. A new red fluorescent protein that allows efficient marking of murine hematopoietic stem cells. J. Gene Med. 2008, 10:965-971.
9. Matsunari H., Onodera M., Tada N., Mochizuki H., Karasawa S., Haruyama E., Nakayama N., Saito H., Ueno S., Kurome M., Miyawaki A., Nagashima H. Transgenic-cloned pigs systemically expressing red fluorescent protein, Kusabira-Orange. Cloning Stem Cells 2008, 10:313-323.
10. Jaenisch R., Harbers K., Schnieke A., Lohler J., Chumakov I., Jahner D., Grotkopp D., Hoffmann E. Germline integration of moloney murine leukemia virus at the Mov13 locus leads to recessive lethal mutation and early embryonic death. Cell 1983, 32:209-216.
11. Jahner D., Stuhlmann H., Stewart C.L., Harbers K., Lohler J., Simon I., Jaenisch R. De novo methylation and expression of retroviral genomes during mouse embryogenesis. Nature 1982, 298:623-628.
12. Robertson E., Bradley A., Kuehn M., Evans M. Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature 1986, 323:445-448.
13. Hamanaka S., Nabekura T., Otsu M., Yoshida H., Nagata M., Usui J., Takahashi S., Nagasawa T., Nakauchi H., Onodera M. Stable transgene expression in mice generated from retrovirally transduced embryonic stem cells. Mol. Ther. 2007, 15:560-565.
14. Suzuki A., Obi K., Urabe T., Hayakawa H., Yamada M., Kaneko S., Onodera M., Mizuno Y., Mochizuki H. Feasibility of ex vivo gene therapy for neurological disorders using the new retroviral vector GCDNsap packaged in the vesicular stomatitis virus G protein. J. Neurochem. 2002, 82:953-960.
15. Doetschman T.C., Eistetter H., Katz M., Schmidt W., Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 1985, 87:27-45.
16. Joyner A.L. Gene Targeting: A Practival Approach 1993, Oxford press, Oxford.
17. Aiuti A., Cassani B., Andolfi G., Mirolo M., Biasco L., Recchia A., Urbinati F., Valacca C., Scaramuzza S., Aker M., Slavin S., Cazzola M., Sartori D., Ambrosi A., Di Serio C., Roncarolo M.G., Mavilio F., Bordignon C. Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy. J. Clin. Invest. 2007, 117:2233-2240.
18. Morita Y., Ema H., Nakauchi H. Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. J. Exp. Med. 2010, 207:1173-1182.